No single NSAID is universally “best” for inflammation. The answer depends on the type of inflammation, where it is in your body, and your personal risk factors. That said, the research consistently points to a few standouts: diclofenac and etoricoxib rank highest for overall inflammatory symptom relief, naproxen performs best for improving joint function, and celecoxib offers the strongest anti-inflammatory effect with the lowest risk of stomach problems.
How NSAIDs Actually Reduce Inflammation
All NSAIDs work by blocking enzymes called COX-1 and COX-2, which your body uses to produce inflammatory chemicals. COX-2 is the main driver of pain, swelling, and redness at injury sites. COX-1, on the other hand, plays a protective role in your stomach lining and kidneys. The ratio of how strongly a drug blocks one enzyme versus the other determines both its effectiveness and its side effect profile.
Older NSAIDs like ibuprofen and indomethacin block both enzymes roughly equally, or even favor COX-1. Ibuprofen’s COX-1/COX-2 ratio is just 0.15, meaning it hits your stomach’s protective enzyme harder than the inflammatory one. Celecoxib has a ratio of 12, making it about 80 times more selective for the inflammation-driving enzyme compared to ibuprofen. Diclofenac falls in between with a ratio of 2.9, giving it moderate COX-2 preference while still being a potent blocker of both pathways.
Which NSAIDs Rank Highest for Inflammation
A large network meta-analysis published in PLOS ONE compared NSAIDs head-to-head across multiple measures of inflammatory symptoms in osteoarthritis patients. The results varied depending on which symptom you’re trying to treat.
For pain specifically, etoricoxib ranked first with an effectiveness probability of 84.4%, followed by naproxen at 79.6% and diclofenac at 71.3%. Etoricoxib didn’t just edge out the competition; it showed statistically significant superiority over several other NSAIDs, including celecoxib. For joint stiffness, a hallmark of active inflammation, diclofenac ranked first at 86.1%. For overall physical function, naproxen came out on top. And when researchers looked at total symptom scores combining pain, stiffness, and function, diclofenac was the most effective overall intervention.
Celecoxib, despite being one of the most commonly prescribed NSAIDs, landed in the middle of the pack for most measures. It performed better than placebo, but it didn’t match diclofenac, etoricoxib, or naproxen for raw anti-inflammatory power.
Over-the-Counter Options: Ibuprofen vs. Naproxen
If you’re choosing between the two NSAIDs available without a prescription in most countries, naproxen has the edge for sustained inflammation. Its longer half-life means you can take it twice a day instead of every four to six hours, keeping more consistent levels in your system. For managing chronic inflammatory pain, this matters. The research ranked naproxen significantly higher than ibuprofen for improving joint dysfunction, and it had a low incidence of adverse events.
Ibuprofen works faster, which makes it better for acute flare-ups where you want quick relief. But there’s a dosing nuance many people miss. Over-the-counter ibuprofen at 200 to 400 mg primarily acts as a pain reliever. To get meaningful anti-inflammatory effects, the dose needs to be higher, in the range of 1,200 to 3,200 mg per day divided into three or four doses. That’s the dosing range used for arthritis, and it carries more risk than the occasional two tablets for a headache.
Why Safety Narrows Your Choices
Raw potency doesn’t tell the whole story. The strongest anti-inflammatory NSAID on paper might be the wrong choice for your body.
Stomach damage is the most common serious risk. NSAIDs that heavily block COX-1 (naproxen, ibuprofen, aspirin) carry higher gastrointestinal risk. Serious complications like bleeding, perforation, or ulcers occur in roughly 2% of average-risk NSAID users per year, climbing to 10% in high-risk patients. COX-2 selective drugs like celecoxib dramatically reduce this risk. In people not taking aspirin, the rate of ulcer complications with celecoxib was 0.44%, nearly identical to the background rate in people not taking any NSAID at all.
Kidney damage is another concern, particularly at higher doses and in older adults. Ibuprofen at doses above 1,200 mg per day has been linked to increased risk of acute kidney injury. Naproxen and ibuprofen are also more frequently associated with a specific type of kidney inflammation that causes significant protein loss. Celecoxib appears to cause less severe kidney symptoms when problems do occur.
Cardiovascular risk is often raised as a concern with COX-2 selective drugs, but the picture is more nuanced than the early headlines suggested. In a population-based study of patients with high blood pressure, researchers found no statistically significant difference in cardiovascular event rates between celecoxib, diclofenac, ibuprofen, and naproxen. Naproxen has traditionally been considered the safest for the heart, but the evidence for a meaningful advantage is not as strong as once thought.
Topical NSAIDs for Localized Inflammation
If your inflammation is in a joint close to the skin’s surface, like a knee or hand, topical NSAIDs deserve serious consideration. The American College of Rheumatology strongly recommends topical NSAIDs for knee osteoarthritis and conditionally recommends them for hand osteoarthritis, suggesting they be tried before oral versions. The logic is straightforward: local treatment means less drug circulating through your entire body.
Topical diclofenac has been the most studied formulation. Reviews comparing it to oral diclofenac found comparable effectiveness for joint inflammation, with far fewer side effects. The drug penetrates the skin and concentrates in the tissue underneath, reaching the inflamed joint without flooding your stomach, kidneys, and cardiovascular system. For deeper joints like the hip, topical options are less effective because the drug can’t penetrate far enough.
Matching the NSAID to Your Situation
For pure anti-inflammatory power with chronic joint inflammation, diclofenac consistently ranks at or near the top across multiple symptom measures. It’s available both as an oral medication and a topical gel, giving you flexibility. Etoricoxib is the strongest option specifically for pain driven by inflammation, though it’s not available in every country (it’s not sold in the United States, for example).
If you need an over-the-counter option for ongoing inflammatory symptoms, naproxen’s twice-daily dosing and strong performance on function scores make it the more practical choice over ibuprofen. For people with a history of stomach ulcers or GI bleeding, celecoxib provides meaningful anti-inflammatory relief with a gastric safety profile close to taking no NSAID at all. And for localized knee or hand inflammation, topical diclofenac matches oral NSAIDs in effectiveness while largely avoiding systemic side effects.
The ACR’s overarching principle is worth keeping in mind: start with whatever gives you the least total-body drug exposure. For a swollen knee, that means trying a topical gel before reaching for pills. For widespread joint inflammation, it means choosing the lowest effective oral dose of an NSAID that balances potency against your individual risk factors for stomach, kidney, and heart problems.